← Leaderboards
Andrew I Flyak
California Institute Of Technology
$756,930
Attributed
$756,930
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2020–23$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$756,930 · 2
By mechanism
R00$498,000 · 1
K99$258,930 · 1
Top collaborators
No co-investigators on record.
Most similar at California Institute Of Technology
Same institution · by research overlap
- Pamela J Bjorkman$57,868,021
- Magnus Adrian Gero Hoffmann$6,053,000
- Michel C Nussenzweig$48,766,293
- Julie Champion$1,984,883
Others in their field
Other Emerging Leaders on “Animal Model”
- Ted Ross · University Of Georgia$71,962,304
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$16,982,327
Research focus
Animal ModelAntibodiesAntibody AvidityAnimalsAntigensAntiviral AgentsAreaAutomobile DrivingAwardAntibody ResponseBindingBinding SitesBiological ModelsBiologyB-LymphocytesCd81 GeneChronicCollaborationsComplexCostDesignEfficacy StudyEnv Gene ProductsEpidemic
Grant awards (4)
Immunization strategies to elicit broadly neutralizing antibodies against HCV$249,000
R00 · FY2023 · AI · contact PI
Immunization strategies to elicit broadly neutralizing antibodies against HCV$249,000
R00 · FY2022 · AI · contact PI
Immunization strategies to elicit broadly neutralizing antibodies against HCV$129,465
K99 · FY2021 · AI · contact PI
Immunization strategies to elicit broadly neutralizing antibodies against HCV$129,465
K99 · FY2020 · AI · contact PI